Begley, David J.

Structure and function of the blood–brain barrier

Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease

Barrier Structure and Function StudiesDrug Transport and Resistance Mechanisms

Cited by 5,185

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities

Begley, D. J. (2004) · Pharmacology & Therapeutics

Barrier Structure and Function StudiesDrug Transport and Resistance Mechanisms

Cited by 679

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones

Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Wagner, S., Büchel, C., von Briesen, H., & Kreuter, J. (2009) · Journal of Controlled Release

Barrier Structure and Function StudiesNanoparticle-Based Drug Delivery

Cited by 438

Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles

Kurakhmaeva, K. B., Djindjikhashvili, I. A., Petrov, V. E., Balabanyan, V. U., Voronina, T. A., Trofimov, S. S., Kreuter, J., Gelperina, S., Begley, D., & Alyautdin, R. N. (2009) · Journal of Drug Targeting

Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery Systems

Cited by 221

Heat shock protein–based therapy as a potential candidate for treating the sphingolipidoses

Kirkegaard, T., Gray, J., Priestman, D. A., Wallom, K.-L., Atkins, J., Olsen, O. D., Klein, A., Drndarski, S., Petersen, N. H. T., Ingemann, L., et al. (2016) · Science Translational Medicine

Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus

Cited by 173

Blood-brain barrier permeability to leucine-enkephalin,d-Alanine2-d-leucine5-enkephalin and their N-terminal amino acid (tyrosine)

Zlokovic, B. V., Begley, D. J., & Chain-Eliash, D. G. (1985) · Brain Research

Barrier Structure and Function StudiesNeuropeptides and Animal Physiology

Cited by 114